Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00024167

Public ClinicalTrials.gov record NCT00024167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radioactive substances such as strontium-89 may relieve bone pain associated with prostate cancer. It is not yet known whether chemotherapy is more effective with or without strontium-89 in treating bone metastases. PURPOSE: This randomized phase III trial is studying giving chemotherapy together with strontium-89 to see how well it works compared to chemotherapy alone in treating patients with prostate cancer that has spread to the bone.

Study identification

NCT ID
NCT00024167
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
265 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Sep 2014 (Actual)
Completion
Not listed
Last update posted
Mar 22, 2016

Started 2002

United States locations

U.S. sites
40
U.S. states
11
U.S. cities
26
Facility City State ZIP Site status
Northeast Georgia Medical Center Gainesville Georgia 30501 —
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
Veterans Affairs Medical Center - Hines Hines Illinois 60141 —
Swedish-American Regional Cancer Center Rockford Illinois 61104-2315 —
Hematology Oncology Associates of the Quad Cities Bettendorf Iowa 52722 —
Genesis Regional Cancer Center at Genesis Medical Center Davenport Iowa 52803 —
Siouxland Hematology-Oncology Associates, LLP Sioux City Iowa 51101 —
Mercy Medical Center - Sioux City Sioux City Iowa 51104 —
St. Luke's Regional Medical Center Sioux City Iowa 51104 —
University of Mississippi Cancer Clinic Jackson Mississippi 39216 —
CCOP - Montana Cancer Consortium Billings Montana 59101 —
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59101 —
Northern Rockies Radiation Oncology Center Billings Montana 59101 —
St. Vincent Healthcare Cancer Care Services Billings Montana 59101 —
Billings Clinic - Downtown Billings Montana 59107-7000 —
Bozeman Deaconess Cancer Center Bozeman Montana 59715 —
St. James Healthcare Cancer Care Butte Montana 59701 —
Big Sky Oncology Great Falls Montana 59405-5309 —
Great Falls Clinic - Main Facility Great Falls Montana 59405 —
Sletten Cancer Institute at Benefis Healthcare Great Falls Montana 59405 —
Not listed Great Falls Montana 59405 —
St. Peter's Hospital Helena Montana 59601 —
Glacier Oncology, PLLC Kalispell Montana 59901 —
Kalispell Medical Oncology at KRMC Kalispell Montana 59901 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Community Medical Center Missoula Montana 59801 —
Guardian Oncology and Center for Wellness Missoula Montana 59804 —
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877 —
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807 —
Good Samaritan Cancer Center at Good Samaritan Hospital Kearney Nebraska 68848-1990 —
Kinston Medical Specialists Kinston North Carolina 28501 —
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090 —
Barberton Citizens Hospital Barberton Ohio 44203 —
Cancer Care Center, Incorporated Salem Ohio 44460 —
Cancer Treatment Center Wooster Ohio 44691 —
McLeod Regional Medical Center Florence South Carolina 29501 —
CCOP - Greenville Greenville South Carolina 29615 —
Medical City Dallas Hospital Dallas Texas 75230 —
University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 —
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00024167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00024167 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →